Naphthyridine derivatives
US4086348A · kind A · utility
3Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 1976 |
| Grant date | Apr 25, 1978 |
| Priority date | — |
| Expiry date | Apr 5, 1996 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C51/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Heterocyclic compounds of the formula: ##STR1## wherein the pyrroline ring and the symbols X.sub.1 and X.sub.2 together form an unsubstituted or substituted isoindoline nucleus, or a 6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine, 6,7-dihydro-5H-pyrrolo[3,4-b]pyridine or 2,3,6,7-tetrahydro-5H-1,4-oxathiino[2,3-c]pyrrole nucleus, the 1,8-naphthyridin-2-yl nucleus is unsubstituted or substituted, and the grouping --NR.sub.1 R.sub.2 is an amino or substituted amino group, are new compounds which are active as tranquillizers, hypnotics, anti-convulsant agents and anti-spasmodics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.